| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88978527 | FILING DATE | 06/27/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | SERVICE MARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | BUONGIORNO, CHRISTOPHE |
L.O. ASSIGNED | 102 |
PUB INFORMATION |
|||
| RUN DATE | 08/29/2020 | ||
| PUB DATE | 06/18/2019 | ||
| STATUS | 819-SU - REGISTRATION REVIEW COMPLETE | ||
| STATUS DATE | 08/28/2020 | ||
| LITERAL MARK ELEMENT | NVS | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | NVS |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Novelstar Pharmaceuticals Inc. |
| ADDRESS | 2005 Eastpark Blvd Cranbury, NJ 08512 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | 01/00/2019 | FIRST USE IN COMMERCE DATE | 09/00/2019 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of a circle with enclosed stylized text which reads "NVS". |
| CHILD OF | 88016697 |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 08/29/2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 033 |
| 08/28/2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 032 |
| 08/13/2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 031 |
| 08/12/2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 030 |
| 07/07/2020 | IUAF | S | USE AMENDMENT FILED | 029 |
| 08/12/2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | 028 |
| 07/07/2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | 027 |
| 08/06/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 026 |
| 07/07/2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | 025 |
| 07/07/2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 024 |
| 02/04/2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 023 |
| 12/26/2019 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 022 |
| 07/11/2019 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | 021 |
| 06/18/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 020 |
| 06/18/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 019 |
| 05/29/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 018 |
| 05/16/2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 017 |
| 05/16/2019 | ALIE | A | ASSIGNED TO LIE | 016 |
| 05/01/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 015 |
| 04/08/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 014 |
| 04/07/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 013 |
| 04/07/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 012 |
| 04/01/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 011 |
| 04/01/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 010 |
| 03/11/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 009 |
| 03/11/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 008 |
| 10/23/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 10/23/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 10/23/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 10/18/2018 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 07/03/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 07/01/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 06/30/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Michael J. Leonard |
| CORRESPONDENCE ADDRESS | Michael J. Leonard Fox Rothschild LLP 997 Lenox Drive, Bldg. 3 Lawrenceville, NJ 08648-2311 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Novelstar Pharmaceuticals Inc. |
| ADDRESS | 2005 Eastpark Blvd Cranbury, NJ 08512 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |